Verition Fund Management
MDT icon

Verition Fund Management’s Medtronic MDT Stock Holding History

Verition Fund Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,300
Closed -$2.05M – 3055
2025
Q4 		$2.05M Sell
21,300
-38,600
-64% -$3.75M 0.01% 1598
2025
Q3 		$5.7M Sell
59,900
-6,600
-10% -$607K 0.02% 1011
2025
Q2 		$5.8M Buy
66,500
+33,800
+103% +$2.87M 0.03% 966
2025
Q1 		$2.94M Sell
32,700
-4,400
-12% -$394K 0.01% 1282
2024
Q4 		$2.96M Sell
37,100
-19,100
-34% -$1.65M 0.01% 1281
2024
Q3 		$5.06M Buy
56,200
+100
+0.2% +$8.41K 0.03% 847
2024
Q2 		$4.42M Hold
56,100
– – 0.02% 796
2024
Q1 		$4.89M Buy
56,100
+30,500
+119% +$2.6M 0.03% 693
2023
Q4 		$2.11M Buy
25,600
+6,000
+31% +$457K 0.02% 807
2023
Q3 		$1.54M Buy
+19,600
New +$1.64M 0.02% 894
2023
Q1 		– Sell
-4,100
Closed -$319K – 2402
2022
Q4 		$319K Hold
4,100
– – 0.01% 1472
2022
Q3 		$331K Buy
+4,100
New +$368K ﹤0.01% 2151
2022
Q2 		– Sell
-7,300
Closed -$810K – 2790
2022
Q1 		$810K Buy
+7,300
New +$771K 0.01% 1610

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Verition Fund Management's MDT Position: Q2 2026 in Review

Verition Fund Management increased its Medtronic (MDT) stake by 968% in Q2 2026, buying an estimated $8.74M and bringing the position to 119,489 shares worth $9.35M. The position accounts for 0.05% of the portfolio, ranked #388.

Verition Fund Management first reported a position in MDT in Q2 2013 and has held it in 49 quarters since. The position peaked at $20.3M in Q2 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Verition Fund Management held 119,489 shares of Medtronic worth $9.35M as of Q2 2026.
  • Verition Fund Management bought 108,303 Medtronic shares in Q2 2026, an estimated $8.74M.
  • Medtronic made up 0.05% of Verition Fund Management's portfolio in Q2 2026, its #388 holding.
  • Verition Fund Management first reported a position in Medtronic in Q2 2013 and has held it in 49 quarters since.
  • Verition Fund Management's Medtronic position peaked at $20.3M in Q2 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.